Rethinking Clinical Trials for Pregnant and Breastfeeding Patients
August 5, 2026
Pregnant and breastfeeding individuals have long been excluded from clinical drug development, leaving physicians and patients to make critical treatment decisions with limited human data. In this timely article, Nonclinical Considerations for Support of Pregnancy and Lactation in Clinical Trials, an international team of experts (including Aclairo’s Ron Wange) explores how drug development can move beyond routine exclusion and toward the safe, ethical inclusion of these underserved populations. The authors examine how current developmental and